5．重要不良事件（Severe Adverse Event）:在用药过程中发生的不良事件和血液学或其他实验室检查明显异常,并且这些不良事件和血液学或其他实验室检查明显异常必须采取针对...
基于28个网页-相关网页
Patient survival and severe adverse event rates were similar in both groups.
两组患者生存率和严重不良事件发生率相似。
The primary end point was dialysis independence at 3 mo. Secondary end points included renal and patient survival at 1 yr and severe adverse event rates.
初级终点为3个月时脱离透析。次级终点包括一年时肾脏和患者生存率以及严重的不良事件。
应用推荐